MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$10,762K
EPS
-$0.33
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development expenses
6,995 13,587* 9,730 7,248
General and administrative expenses
4,718 3,914* 4,604 4,677
Total operating expenses
11,713 17,500 14,334 11,925
Loss from operations
-11,713 -17,500* -14,334 -11,925
Interest income and other, net
1,063 1,404 1,426 1,539
Total other income
1,063 1,404* 1,426 1,539
Net loss
-10,650 -16,097* -12,908 -10,386
Net unrealized gain (loss) on marketable securities
-112 -104* 41 -45
Total comprehensive loss
-10,762 -16,201 -12,867 -10,431
Basic EPS
-0.33 -0.5 -0.4 -0.32
Diluted EPS
-0.33 -0.5 -0.4 -0.32
Basic Average Shares
32,559,704 32,376,316 32,464,893 32,195,366
Diluted Average Shares
32,559,704 32,376,316 32,464,893 32,195,366
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$10,762K Interest income andother, net$1,063K Net loss-$10,650K Net unrealized gain(loss) on marketable...-$112K Total other income$1,063K Loss from operations-$11,713K Total operatingexpenses$11,713K Research and developmentexpenses$6,995K General andadministrative expenses$4,718K

Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Inc. (SGMT)